Neo-/adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients with high-risk early breast cancer: Results on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback